Sandra Hervás-Stubbs (Sandra Hervas-Stubbs)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Topics

Epidermal Growth Factor Receptor

Acute Lymphoblastic Leukemia

Top Venues

Journal for immunotherapy of cancer

British journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Inés Sánchez-Moreno, Aritz Lasarte-Cia, Celia Martín-Otal, Noelia Casares, Flor Navarro, Marta Gorraiz, Patricia Sarrión, Sandra Hervás-Stubbs, Lorea Jordana, Juan Roberto Rodriguez-Madoz, Jesús San Miguel, Felipe Prosper, Juan Jose Lasarte, Teresa Lozano
Tethered IL15-IL15Rα augments antitumor activity of CD19 CAR-T cells but displays long-term toxicity in an immunocompetent lymphoma mouse model. Journal for immunotherapy of cancer 12 (7) (2024)
Inés Sánchez-Moreno, Aritz Lasarte-Cia, Celia Martín-Otal, Noelia Casares, Flor Navarro, Marta Gorraiz, Patricia Sarrión, Sandra Hervás-Stubbs, Lorea Jordana, Juan Roberto Rodriguez-Madoz, Jesús San Miguel, Felipe Prosper, Juan Jose Lasarte, Teresa Lozano
Tethered IL15-IL15Rα augments antitumor activity of CD19 CAR-T cells but displays long-term toxicity in an immunocompetent lymphoma mouse model. Journal for immunotherapy of cancer 12 (7) (2024)
Inés Sánchez-Moreno, Aritz Lasarte-Cia, Celia Martín-Otal, Noelia Casares, Flor Navarro, Marta Gorraiz, Patricia Sarrión, Sandra Hervás-Stubbs, Lorea Jordana, Juan Roberto Rodriguez-Madoz, Jesús San Miguel, Felipe Prosper, Juan Jose Lasarte, Teresa Lozano
Tethered IL15-IL15Rα augments antitumor activity of CD19 CAR-T cells but displays long-term toxicity in an immunocompetent lymphoma mouse model. Journal for immunotherapy of cancer 12 (7) (2024)
Celia Martín-Otal, Aritz Lasarte-Cia, Diego Serrano, Noelia Casares, Enrique Conde, Flor Navarro, Inés Sánchez-Moreno, Marta Gorraiz, Patricia Sarrión, Alfonso Calvo, Carlos E De Andrea, José Echeveste, Amaia Vilas, Juan Roberto Rodriguez-Madoz, Jesús San Miguel, Felipe Prosper, Sandra Hervás-Stubbs, Juan Jose Lasarte, Teresa Lozano
Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells. Journal for immunotherapy of cancer 10 (8) (2022)
Borja Ruiz-Fernández de Córdoba, Haritz Moreno, Karmele Valencia, Naiara Perurena, Pablo Ruedas, Thomas Walle, Alberto Pezonaga-Torres, Juan Hinojosa, Elisabeth Guruceaga, Antonio Pineda-Lucena, Marta Abengózar-Muela, Denis Cochonneau, Carolina Zandueta, Susana Martínez-Canarias, Alvaro Teijeira, Daniel Ajona, Sergio Ortiz Espinosa, Xabier Morales, Carlos Ortiz de Solórzano, Marta Santisteban, Luis I Ramos-García, Laura Guembe, Vratislav Strnad, Dominique Heymann, Sandra Hervás-Stubbs, Ruben Pio, María E Rodríguez-Ruiz, Carlos E de Andrea, Silvestre Vincent, Ignacio Melero Bermejo, Fernando Lecanda, Rafael Martinez-Monge
Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer. Cancer discovery 12 (5) (2022)
Enrique Conde, Enric Vercher, Marta Soria-Castellano, Jesús Suarez-Olmos, Uxua Mancheño, Edurne Elizalde, M Luis Rodriguez, Javier Glez-Vaz, Noelia Casares, Estefanía Rodríguez-García, Mirja Hommel, Gloria González-Aseguinolaza, Iratxe Uranga-Murillo, Julian Pardo, Gorka Alkorta, Ignacio Melero Bermejo, Juan Jose Lasarte, Sandra Hervás-Stubbs
Epitope spreading driven by the joint action of CART cells and pharmacological STING stimulation counteracts tumor escape via antigen-loss variants. Journal for immunotherapy of cancer 9 (11) (2022)
Flor Navarro, Noelia Casares, Celia Martín-Otal, Aritz Lasarte-Cía, Marta Gorraiz, Patricia Sarrión, Diana Llopiz, David Repáraz, Nerea Varo, Juan Roberto Rodriguez-Madoz, Felipe Prosper, Sandra Hervás-Stubbs, Teresa Lozano, Juan Jose Lasarte
Overcoming T cell dysfunction in acidic pH to enhance adoptive T cell transfer immunotherapy. Oncoimmunology 11 (1) (2022)
David Repáraz, Marta Ruiz, Diana Llopiz, Leyre Silva, Enric Vercher, Belén Aparicio, Josune Egea, Ibon Tamayo-Uria, Sandra Hervás-Stubbs, Jorge García-Balduz, Carla Castro, Mercedes Iñarrairaegui, Maria Tagliamonte, Angela Mauriello, Beatrice Cavalluzzo, Luigi Buonaguro, Charlotte Rohrer, Kathrin Heim, Catrin Tauber, Maike Hofmann, Robert Thimme, Bruno Sangro, Pablo Sarobe
Neoantigens as potential vaccines in hepatocellular carcinoma. Journal for immunotherapy of cancer 10 (2) (2022)
Marina Barriocanal, Celia Prior, Beatriz Suarez, Juan Pablo Unfried, Nerea Razquin, Sandra Hervás-Stubbs, Bruno Sangro, Victor Segura, Puri Fortes
Long Noncoding RNA EGOT Responds to Stress Signals to Regulate Cell Inflammation and Growth. Journal of immunology (Baltimore, Md. : 1950) 206 (8) (2021)
Maria Buñuales, Maria Cristina Ballesteros-Briones, Manuela Gonzalez-Aparicio, Sandra Hervás-Stubbs, Eva Martisova, Uxua Mancheño, Ana Ricobaraza, Sara Lumbreras, Cristian Smerdou, Ruben Hernandez-Alcoceba
Adenovirus-Mediated Inducible Expression of a PD-L1 Blocking Antibody in Combination with Macrophage Depletion Improves Survival in a Mouse Model of Peritoneal Carcinomatosis. International journal of molecular sciences 22 (8) (2021)
Bruno Sangro, Pablo Sarobe, Sandra Hervás-Stubbs, Ignacio Melero Bermejo
Advances in immunotherapy for hepatocellular carcinoma. Nature reviews. Gastroenterology & hepatology 18 (8) (2021)
Diego Salas-Benito, Enrique Conde, Ibon Tamayo-Uria, Uxua Mancheño, Edurne Elizalde, David Garcia-Ros, José Manuel Aramendía, Juan Carlos Muruzábal, Julia Alcaide, Francisco Guillen-Grima, Jose A Minguez, Jose Amores-Tirado, Antonio Gonzalez-Martin, Pablo Sarobe, Juan J Lasarte, Mariano Ponz-Sarvisé, Carlos E De Andrea, Sandra Hervás-Stubbs
The mutational load and a T-cell inflamed tumour phenotype identify ovarian cancer patients rendering tumour-reactive T cells from PD-1+ tumour-infiltrating lymphocytes. British journal of cancer 124 (6) (2021)
Noelia Silva-Pilipich, Eva Martisova, María Cristina Ballesteros-Briones, Sandra Hervás-Stubbs, Noelia Casares, Gualberto González-Sapienza, Cristian Smerdou, Lucia Vanrell
Long-Term Systemic Expression of a Novel PD-1 Blocking Nanobody from an AAV Vector Provides Antitumor Activity without Toxicity. Biomedicines 8 (12) (2020)
Marién Pascual, María Mena-Varas, Eloy Francisco Robles, Maria-Jose Garcia-Barchino, Carlos Panizo, Sandra Hervás-Stubbs, Diego Alignani, Ainara Sagardoy, Jose Ignacio Martinez-Ferrandis, Karen L Bunting, Stephen Meier, Xavier Sagaert, Davide Bagnara, Elisabeth Guruceaga, Oscar Blanco, Jon Celay, Alvaro Martínez-Baztan, Noelia Casares, Juan Jose Lasarte, Thomas MacCarthy, Ari M Melnick, Jose-Angel Martinez-Climent, Sergio Roa
PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas. Blood 133 (22) (2019)